Atara Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 05/15/2025 | 573.18 K | $3.40 B | 7.71% | 5.33% |
| REDMILE GROUP, LLC | 05/15/2025 | 441.70 K | $2.62 M | 0.00% | 4.10% |
| VANGUARD GROUP INC | 05/09/2025 | 190.76 K | $1.13 M | 6.70% | 1.77% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 187.30 K | $1.11 M | -8.71% | 1.74% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 115.11 K | $682.00 K | -7.52% | 1.07% |
| VESTAL POINT CAPITAL, LP | 05/15/2025 | 94.09 K | $558.87 K | -24.73% | 0.87% |
| STALEY CAPITAL ADVISERS INC | 05/12/2025 | 80.00 K | $475.20 K | 60.00% | 0.74% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 75.20 K | $446.66 K | 0.00% | 0.70% |
| BLACKROCK, INC. | 05/02/2025 | 60.80 K | $361.14 K | -0.08% | 0.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 58.68 K | $348.63 K | 7.19% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 41.01 K | $243.62 K | 100.00% | 0.38% |
| STATE STREET CORP | 05/15/2025 | 25.25 K | $150.00 K | 0.00% | 0.23% |
| BIRCHVIEW CAPITAL, LP | 05/15/2025 | 22.00 K | $130.68 K | 0.00% | 0.20% |
| GSA CAPITAL PARTNERS LLP | 05/08/2025 | 19.39 K | $115.00 K | 100.00% | 0.18% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 17.44 K | $103.57 K | -74.03% | 0.16% |
| FMR LLC | 05/12/2025 | 17.16 K | $101.91 K | -35.74% | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 14.00 K | $83.16 K | 0.00% | 0.13% |
| MORGAN STANLEY | 05/15/2025 | 11.83 K | $70.26 K | -58.28% | 0.11% |
| NORTHERN TRUST CORP | 05/13/2025 | 11.17 K | $66.35 K | 0.00% | 0.10% |
| 05/02/2025 | 1.40 K | $8.34 K | -0.85% | 0.01% | |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 951 | $5.65 K | 0.00% | 0.01% |
| ROYAL BANK OF CANADA | 05/15/2025 | 850 | $5.00 K | 924.10% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 703 | $4.59 K | 246.31% | 0.01% |
| SVB WEALTH LLC | 05/14/2025 | 421 | $2.50 K | 100.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 368 | $2.19 K | -48.82% | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 05/15/2025 | 368 | $2.00 K | -17.12% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 216 | $1.28 K | 0.00% | 0.00% |
| 05/09/2025 | 200 | $1.19 K | 100.00% | 0.00% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 185 | $1.10 K | 164.29% | 0.00% |
| IFP ADVISORS, INC | 05/05/2025 | 180 | $1.07 K | 0.00% | 0.00% |
| 05/15/2025 | 176 | $966 | 0.00% | 0.00% | |
| RHUMBLINE ADVISERS | 04/08/2025 | 175 | $1.04 K | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 148 | $879 | -62.44% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 50 | $297 | -18.03% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 10 | $59 | -98.33% | 0.00% |
| CITIGROUP INC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| 05/09/2025 | 0 | $0 | -100.00% | 0.00% | |
| GAMMA INVESTING LLC | 04/15/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 (DIFC) LTD | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Atara Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 79 institutional investors and hedge funds held shares of Atara Biotherapeutics, Inc.. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 573,183
Redmile Group, LLC: 441,701
VANGUARD GROUP INC: 190,761
BANK OF AMERICA CORP /DE/: 187,297
ACADIAN ASSET MANAGEMENT LLC: 115,111
Vestal Point Capital, LP: 94,085
19.38% of Atara Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.18 M shares in the last 24 months. This purchase volume represents approximately $55.94 M in transactions.